Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Merkel Cell

Explore clinical trials studying Carcinoma, Merkel Cell. Study availability and eligibility vary by location and protocol.

106 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Merkel Cell trial results

Active, not recruiting

Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma

NCT04291885

Conditions
Adenocarcinoma, Carcinoma, Carcinoma Neuroendocrine Skin, +18 more
Locations
  • Port Macquarie Base Hospital Port Macquarie, New South Wales, Australia
  • Chris O'Brien Lifehouse Sydney, New South Wales, Australia
  • Melanoma Institute Australia Sydney, New South Wales, Australia
  • Royal North Shore Hospital Sydney, New South Wales, Australia
View all 20 locations
View Trial Details
Active, not recruiting

Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

NCT04792073

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Active, not recruiting

Targeted Therapy and Avelumab in Merkel Cell Carcinoma

NCT04261855

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • Mid North Coast Cancer Institute - Coffs Harbour Health Campus Coffs Harbour, New South Wales, Australia
  • Lake Macquarie Private Hospital Gateshead, New South Wales, Australia
  • Gosford Hospital Gosford, New South Wales, Australia
  • Wyong Hospital Hamlyn Terrace, New South Wales, Australia
View Trial Details
Active, not recruiting

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

NCT03228667

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +79 more
Locations
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • MemorialCare Health System Fountain Valley, California, United States
View all 35 locations
View Trial Details
Active, not recruiting

BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors

NCT05120271

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
Locations
  • Hoag Hospital Newport Beach Newport Beach, California, United States
  • Baylor Scott and White Research Institute Dallas, Texas, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Center - Seattle Cancer Care Alliance (SCCA) Location Seattle, Washington, United States
View Trial Details
Active, not recruiting

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

NCT03212404

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +67 more
Locations
  • Research Site Wollongong, New South Wales, Australia
  • Research Site Benowa, Queensland, Australia
  • Research Site Buderim, Queensland, Australia
  • Research Site Greenslopes, Queensland, Australia
View all 48 locations
View Trial Details

Related conditions